Posts by: Carolina Henriques

Carolina Henriques

Carolina holds a BSc in Anthropology and a MSc in Urban Studies., and brings her interdisciplinary skills to her writing on a range of different topics in science, research and advocacy news.

November 1, 2016November 1, 2016

Regular Visits to Dentist and Good Oral Hygiene May Help Prevent Pneumonia, Study Finds

A new research study has shown that good oral hygiene can reduce bacteria known to cause pneumonia. Going to the dentist every six months could be more helpful to keep ... Read more

October 25, 2016October 25, 2016

New Data on Antibiotic to Treat CABP, Now in Phase 3 Trial, Being Presented at IDWeek 2016

Nabriva Therapeutics recently announced that it will present two posters on the company’s clinical-stage antibiotic, lefamulin, currently being developed for the treatment of community acquired bacterial pneumonia (CABP). The data will be presented at IDWeek ... Read more

September 22, 2016September 22, 2016

Occupational Therapy Seen to Lower Likelihood of Hospital Readmission in Pneumonia Cases

Researchers, in a recent study, found that the more a hospital invests in occupational therapy the lower are its readmission rates for three serious health conditions: pneumonia, heart failure, and acute myocardial infarction. ... Read more

September 20, 2016September 20, 2016

N1 Technologies Requests Patent of Bacteriophage to Treat Antibiotic-Resistant Pneumonias

N1 Technologies recently announced that the company has filed a biotech patent with the United States Patent and Trademark Office (USPTO) for its Viritron VPN, an in-development bacteriophage treatment for patients with pneumonia. ... Read more

August 18, 2016

Super Vaccine in Development to Fight All Strains of Pneumococcal Disease

Researchers are developing a new super vaccine called G-PN that is powerful enough to battle all 90 known strains of pneumococcal disease, a bacterial infection that can lead to pneumonia and other diseases. ... Read more

August 4, 2016

AmpliPhi Completes Enrollment in Drug Trial for Hospital-Acquired Pneumonia, Other Infections

AmpliPhi Biosciences has completed enrollment for a Phase 1 clinical trial to evaluate the safety of AB-SAB01, its proprietary bacteriophage cocktail against Staphylococcus aureus (S. aureus) infections. Despite strong eradication efforts, S. ... Read more

August 1, 2016August 1, 2016

Doctors Without Borders Calls for Affordable Pneumonia Vaccines Before Pfizer’s Patent Hearing in India

Doctors Without Borders has established a new Access Campaign initiative ahead of Pfizer’s pneumonia patent hearing in India. In March 2016, the organization filed a “patent opposition” to prevent American pharmaceutical ... Read more

July 7, 2016

NDA for Solithera to Treat Pneumonia Accepted by FDA

The U.S. FDA has accepted two new drug applications (NDAs) from Cempra, which develops antibiotics for bacterial infectious diseases, for Solithera (solithromycin) as a treatment for community-acquired bacterial pneumonia (CABP). The FDA’s ... Read more

May 13, 2016May 20, 2016

Phase 3 Trial Data on Pneumonia Drug Telavancin Presented by Theravance Biopharma

Ireland-based Theravance Biopharma presented new data on Vibativ (telavancin) for the treatment of pneumonia at the American Thoracic Society’s International Conference May 13-18 in in San Francisco. The poster-presentation data, titled “Clinical Efficacy and ... Read more

May 10, 2016May 10, 2016

A Blanket for Incubator Tubes Helps Premature Babies Survive

Researchers from a start-up company called Vincent’s Solutions, based at the University of California (UC) Merced, have developed a special blanket – not to help babies sleep – but to ... Read more